Correlation Between Transcode Therapeutics and Galecto

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Galecto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Galecto into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Galecto, you can compare the effects of market volatilities on Transcode Therapeutics and Galecto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Galecto. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Galecto.

Diversification Opportunities for Transcode Therapeutics and Galecto

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Transcode and Galecto is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Galecto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galecto and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Galecto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galecto has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Galecto go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and Galecto

Given the investment horizon of 90 days Transcode Therapeutics is expected to generate 38.38 times less return on investment than Galecto. But when comparing it to its historical volatility, Transcode Therapeutics is 7.03 times less risky than Galecto. It trades about 0.02 of its potential returns per unit of risk. Galecto is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  341.00  in Galecto on September 26, 2025 and sell it today you would earn a total of  2,608  from holding Galecto or generate 764.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.21%
ValuesDaily Returns

Transcode Therapeutics  vs.  Galecto

 Performance 
       Timeline  
Transcode Therapeutics 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors.
Galecto 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Galecto are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Galecto displayed solid returns over the last few months and may actually be approaching a breakup point.

Transcode Therapeutics and Galecto Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Transcode Therapeutics and Galecto

The main advantage of trading using opposite Transcode Therapeutics and Galecto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Galecto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will offset losses from the drop in Galecto's long position.
The idea behind Transcode Therapeutics and Galecto pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stocks Directory
Find actively traded stocks across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings